Alyeska Investment Group L.P. Purchases Shares of 239,202 Tempus AI, Inc. (NASDAQ:TEM)

Alyeska Investment Group L.P. acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 239,202 shares of the company's stock, valued at approximately $8,075,000. Alyeska Investment Group L.P. owned approximately 0.15% of Tempus AI as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Operose Advisors LLC acquired a new stake in shares of Tempus AI during the 4th quarter worth about $25,000. Farther Finance Advisors LLC acquired a new stake in shares of Tempus AI during the fourth quarter worth approximately $34,000. Prestige Wealth Management Group LLC boosted its holdings in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after acquiring an additional 965 shares in the last quarter. NewEdge Advisors LLC bought a new stake in Tempus AI during the 4th quarter worth approximately $49,000. Finally, First Horizon Advisors Inc. raised its position in Tempus AI by 207.9% in the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock valued at $55,000 after purchasing an additional 1,108 shares during the last quarter. Institutional investors own 24.22% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on TEM shares. JPMorgan Chase & Co. cut Tempus AI from an "overweight" rating to a "neutral" rating and increased their target price for the stock from $50.00 to $55.00 in a report on Tuesday, February 25th. Wolfe Research cut shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Guggenheim reiterated a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Loop Capital lowered their price objective on Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research report on Tuesday, January 14th. Finally, TD Cowen reaffirmed a "buy" rating and issued a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Six investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $61.08.

Tempus AI Stock Down 5.2 %

TEM stock opened at $54.07 on Tuesday. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business's 50-day moving average price is $47.95 and its two-hundred day moving average price is $50.69.

Insider Activity

In related news, EVP Erik Phelps sold 5,934 shares of the firm's stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $67.57, for a total transaction of $400,960.38. Following the sale, the executive vice president now directly owns 214,662 shares in the company, valued at $14,504,711.34. This trade represents a 2.69 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Nadja West sold 809 shares of the company's stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $51.11, for a total transaction of $41,347.99. Following the completion of the transaction, the director now directly owns 37,705 shares of the company's stock, valued at approximately $1,927,102.55. The trade was a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,388,938 shares of company stock worth $261,736,880 in the last 90 days. Corporate insiders own 27.60% of the company's stock.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.